Dr. Michael Seidman is Participating in a New Study to Test Treatment for Blast-induced Tinnitus.

Recent research led by AdventHealth’s Translational Research Institute and others reveals that Type 1 diabetes develops gradually and can now be detected early through blood tests, opening the door to...

The AdventHealth Research team recently completed Core Training for the INNOVATE 2254936 Vidic trial, bringing this novel device to AdventHealth.

AdventHealth Neuroscience Institute is launching THRIVE, a new NIH-funded clinical trial led by geriatric neuropsychologist and neuroscience researcher Lauren Oberlin, PhD.

AdventHealth Research Institute (AHRI) is proud to be the highest enrolling site in the United States for the STAR trial.

A controlled dietary study found that a high-fiber, microbiome-enhancing diet altered gut metabolites, reduced energy absorption, and unexpectedly mimicked fasting effects, offering new insights into...

What if hitting the gym could actually make your brain younger? A new study suggests it can. Our research group found that adults who committed to a year of moderate-to-vigorous aerobic exercise—like...

AdventHealth Research Institutes own Dr. Kirk Erickson was recently featured on Fox 35 to talk about the connection between physical activity and brain health.

On August 8, 2025, our team successfully completed the very first implant day for the Conform Clinical Trial, enrolling and treating our first three patients with the Conformal CLAAS System for Left...

In our latest Clinician’s View, Dr. Patel shares his team’s telesurgery journey, including how they are ensuring safety, quality and ethical exploration of this innovative approach.

We’re proud to announce that Stephanie Compton, PhD, a valued post‑doctoral researcher at the AdventHealth Research Institute, was recently featured by the American Cancer Society.

Starting school is exciting and for families managing T1D, a little planning can make all the difference.

We are proud to announce the launch of the new RISE study.